Overview
Balance Sheet
Cash Flow
Growth Analysis
2023
2022
2021
2020
2019
Profitability Metrics
Gross Margin
70.23%
Operating Margin
37.70%
Net Margin
3.59%
Efficiency Metrics
Revenue per Expense Ratio
1.61
R&D as % of Revenue
0.00%
Earnings Quality
EBITDA Margin
50.20%
Income Tax Rate
0.00%
EPS
0.5400000000
Balance Sheet Analysis
Current Ratio
0.92
Cash Ratio
0.31
Working Capital
$-169.01M
Debt to Equity
0.63
Debt to Assets
31.81%
Equity Ratio
50.23%
Cash Flow Analysis
Operating Cash Flow Ratio
56.50%
Free Cash Flow Ratio
-29.72%
CapEx to Revenue
86.23%
Dividends Paid
$847.48M
Stock Buybacks
$24.59M
Total Shareholder Returns
$872.08M
Cash Position Change
-22.98%
Key Takeaways (2023 FY)
Increased dividend payments by 5.79%
Detailed Growth Metrics
Core Performance
Revenue
11.46%
Net Income
-80.13%
EPS
-83.02%
Operating Income
73.52%
Operational Efficiency
R&D Expenses
-100.00%
SG&A Expenses
12.45%
Operating Cash Flow
25.98%
Free Cash Flow
25.98%
Balance Sheet Health
Assets
3.51%
Debt
15.15%
Book Value per Share
-5.66%
Inventory
33.65%
Shareholder Returns
Dividends per Share
5.79%
Shares Outstanding
5.72%
Long Term Trends
3Y Revenue/Share
12.92%
5Y Revenue/Share
31.02%
3Y Dividend/Share
17.33%
5Y Dividend/Share
32.39%